Bete, Baby Boy B.

HRN: 28-90-18  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/23/2026
CEFUROXIME 750MG (VIAL)
04/23/2026
04/30/2026
IV
350mg
Q8h
Scald Burn
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: